134 related articles for article (PubMed ID: 34369435)
1. Fertility and Pregnancy Outcomes After Conservative Management of Adenocarcinoma In Situ of the Cervix.
Bell SG; Peng K; Kobernik EK; Miller ME; Lieberman R; Saunders NA; Welch KC; Campbell EJ
J Low Genit Tract Dis; 2021 Oct; 25(4):270-275. PubMed ID: 34369435
[TBL] [Abstract][Full Text] [Related]
2. Conservative management of adenocarcinoma in situ of the cervix.
Shin CH; Schorge JO; Lee KR; Sheets EE
Gynecol Oncol; 2000 Oct; 79(1):6-10. PubMed ID: 11006022
[TBL] [Abstract][Full Text] [Related]
3. [Risk stratified management of cervical adenocarcinoma in situ based on cone margin state].
Huang SS; Sui L; Chen LM; Zhang HW; Tao X
Zhonghua Fu Chan Ke Za Zhi; 2021 Sep; 56(9):622-629. PubMed ID: 34547863
[No Abstract] [Full Text] [Related]
4. Endocervical curettage at conization to predict residual cervical adenocarcinoma in situ.
Lea JS; Shin CH; Sheets EE; Coleman RL; Gehrig PA; Duska LR; Miller DS; Schorge JO
Gynecol Oncol; 2002 Oct; 87(1):129-32. PubMed ID: 12468353
[TBL] [Abstract][Full Text] [Related]
5. Fertility-sparing surgery in 101 women with adenocarcinoma in situ of the cervix.
Bull-Phelps SL; Garner EI; Walsh CS; Gehrig PA; Miller DS; Schorge JO
Gynecol Oncol; 2007 Nov; 107(2):316-9. PubMed ID: 17689593
[TBL] [Abstract][Full Text] [Related]
6. Fertility sparing treatment for in situ and early invasive adenocarcinoma of the cervix.
McHale MT; Le TD; Burger RA; Gu M; Rutgers JL; Monk BJ
Obstet Gynecol; 2001 Nov; 98(5 Pt 1):726-31. PubMed ID: 11704160
[TBL] [Abstract][Full Text] [Related]
7. Management and follow-up of patients with adenocarcinoma in situ of the uterine cervix.
Poynor EA; Barakat RR; Hoskins WJ
Gynecol Oncol; 1995 May; 57(2):158-64. PubMed ID: 7729727
[TBL] [Abstract][Full Text] [Related]
8. The status and distance of cone biopsy margins as a predictor of excision adequacy for endocervical adenocarcinoma in situ.
Goldstein NS; Mani A
Am J Clin Pathol; 1998 Jun; 109(6):727-32. PubMed ID: 9620030
[TBL] [Abstract][Full Text] [Related]
9. Predictors of residual carcinoma or carcinoma-in-situ at hysterectomy following cervical conization with positive margins.
Diaz ES; Aoyama C; Baquing MA; Beavis A; Silva E; Holschneider C; Cass I
Gynecol Oncol; 2014 Jan; 132(1):76-80. PubMed ID: 24262876
[TBL] [Abstract][Full Text] [Related]
10. Risk of residual disease and invasive carcinoma in women treated for adenocarcinoma in situ of the cervix.
Costales AB; Milbourne AM; Rhodes HE; Munsell MF; Wallbillich JJ; Brown J; Frumovitz M; Ramondetta LM; Schmeler KM
Gynecol Oncol; 2013 Jun; 129(3):513-6. PubMed ID: 23541795
[TBL] [Abstract][Full Text] [Related]
11. Endocervical curettage, cone margins, and residual adenocarcinoma in situ of the cervix.
Denehy TR; Gregori CA; Breen JL
Obstet Gynecol; 1997 Jul; 90(1):1-6. PubMed ID: 9207802
[TBL] [Abstract][Full Text] [Related]
12. Cervical adenocarcinoma in situ during pregnancy and subsequent fertility-sparing therapy challenge.
Sánchez-Cuerda C; Cuadra M; Gámir S; Lobo P; Elices M; Cabrera Y
Int J Gynaecol Obstet; 2022 Jul; 158(1):21-26. PubMed ID: 34559882
[TBL] [Abstract][Full Text] [Related]
13. [Clinical significance of loop electrosurgical excisional procedure in diagnosis and treatment of cervical adenocarcinoma in situ and invasive cervical adenocarcinoma].
Song Y; Wang Q; Sui L; Gao SJ
Zhonghua Fu Chan Ke Za Zhi; 2018 Mar; 53(3):178-182. PubMed ID: 29609232
[No Abstract] [Full Text] [Related]
14. Cervical conization of adenocarcinoma in situ: a predicting model of residual disease.
Tierney KE; Lin PS; Amezcua C; Matsuo K; Ye W; Felix JC; Roman LD
Am J Obstet Gynecol; 2014 Apr; 210(4):366.e1-366.e5. PubMed ID: 24370689
[TBL] [Abstract][Full Text] [Related]
15. Risk for residual adenocarcinoma in situ or cervical adenocarcinoma in women undergoing loop electrosurgical excision procedure/conization for adenocarcinoma in situ.
DeSimone CP; Day ME; Dietrich CS; Tovar MM; Modesitt SC
J Reprod Med; 2011; 56(9-10):376-80. PubMed ID: 22010519
[TBL] [Abstract][Full Text] [Related]
16. Management and long-term outcomes of women with adenocarcinoma in situ of the cervix: A retrospective study.
Tan JHJ; Malloy MJ; Thangamani R; Gertig D; Drennan KT; Wrede CD; Saville M; Quinn M
Aust N Z J Obstet Gynaecol; 2020 Feb; 60(1):123-129. PubMed ID: 31578727
[TBL] [Abstract][Full Text] [Related]
17. Conservative Treatment for Patients with Carcinoma in Situ-Positive Margins After a Loop Electroexcisional Procedure: Is It Safe?
Chong GO; Lee YH; Lee YS; Cho YL; Park JY; Hong DG
J Reprod Med; 2017; 62(1-2):37-44. PubMed ID: 29999280
[TBL] [Abstract][Full Text] [Related]
18. Risk of persistent or recurrent neoplasia in conservatively treated women with cervical adenocarcinoma in situ with negative histological margins.
Munro A; Codde J; Spilsbury K; Stewart CJ; Steel N; Leung Y; Tan J; Salfinger SG; Mohan GR; Semmens JB; Cohen PA
Acta Obstet Gynecol Scand; 2017 Apr; 96(4):432-437. PubMed ID: 28181670
[TBL] [Abstract][Full Text] [Related]
19. Adenocarcinoma
Kasuga Y; Ikenoue S; Nishio H; Yamagami W; Ochiai D; Tanabe K; Tashima Y; Hirao N; Miyakoshi K; Kasai K; Suda Y; Nemoto T; Shiraishi S; Yoshida H; Kurahashi T; Takamatsu K; Iwasaki S; Yamashita H; Akiba Y; Arase T; Hara S; Nakada S; Tanaka M; Aoki D
J Matern Fetal Neonatal Med; 2022 Dec; 35(25):9837-9842. PubMed ID: 35341455
[TBL] [Abstract][Full Text] [Related]
20. Clinical outcomes of patients with adenocarcinoma in situ of the cervix treated by conization.
Taylor JS; Panico V; Caputo T; Gerber D; Gupta D; Pirog E; Holcomb K
Eur J Gynaecol Oncol; 2014; 35(6):641-5. PubMed ID: 25556268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
